Brought to you by:
F/BEVAR review reveals less than 20% of patients suffered intraoperative adverse event
A retrospective evaluation of 600 fenestrated or branched endovascular aneurysm repairs (F/BEVARs) for the treatment of complex aneurysms revealed that fewer than one in five patients experienced an intraoperative adverse event, according to a press release announcing study results published…
Biomarkers of heart failure show early reversal with catheter thrombolysis compared to anticoagulation alone in a secondary analysis of the SUNSET sPE trial
In a secondary analysis of the SUNSET sPE randomized control trial, lead investigator Efthymios Avgerinos, MD, of the division of vascular surgery, University of Pittsburgh Medical Centre, Pittsburgh, Pennsylvania, and colleagues found differences in biomarker levels in response to treatment…
Dedicated vs. non-dedicated: Researchers place venous stenting under the spotlight at AVF 2022
Venous stenting was a hot topic on the agenda of the recent American Venous Forum (AVF) annual meeting, held this year Feb. 23–26 in Orlando, Florida. Catching the audience’s attention, researchers highlighted a head-to-head study of dedicated versus non-dedicated stents, as…
PROMISE II U.S. pivotal trial of device designed for ‘no-option’ CLTI patients completes enrollment
Enrollment has been completed in the PROMISE II pivotal trial of the LimFlow deep vein arterialization system designed to prevent amputations in so-called “no-option” chronic limb-threatening ischemia (CLTI) patients, the eponymous device maker announced today. “The PROMISE II investigators are…
Viabahn use in claudicants with long, complex SFA lesions ‘safe and effective’ through five years
Recently published research indicates that stent grafting with the Viabahn endoprosthesis (W L Gore & Associates) of long and complex superficial femoral artery (SFA) lesions in patients with claudication is a safe and effective long-term treatment option. Writing in the Journal of Vascular…
The top 10 most popular Vascular Specialist stories in February
February’s top 10 includes a highlight from the 2022 Vascular and Endovascular Surgery Society (VESS) winter annual meeting and an interview with Melissa Kirkwood, MD, and colleagues at UT Southwestern in Dallas, Texas, regarding the lightweight shield designed to reduce…
Lesson learned: Entering vascular residency during first wave of pandemic
An insight into the benefits of virtual learning from the perspective of a medical student on the cusp of residency as the early stages of the pandemic played out was delivered during the most recent Society for Vascular Surgery (SVS)…
New JVS editorial leadership structure announced
The Executive Board of the Society for Vascular Surgery (SVS) recently revealed the new composition of the Journal of Vascular Surgery (JVS) publications‘ senior leadership. The changes are set to take effect on July 1. The editorial structure atop the…
Writing and reviewing in the DEI space: Progress evident but ‘there’s a lot of work to do’
It’s been more than 18 months since the Journal of Vascular Surgery (JVS) implemented changes aimed in part at diversifying involvement with the publication and addressing how papers on social determinants of health are written and reviewed. Part of that…
Venous stents remain durable following pregnancy, researchers find
Iliac vein stents tolerate a gravid uterus well and a possible future pregnancy should not contraindicate their usage in the treatment of pelvic venous insufficiency (PVI), according to new research published in the Journal of Vascular Surgery: Venous and Lymphatic…